AGL38.22▲ 0.07 (0.00%)AIRLINK128.97▲ 3.9 (0.03%)BOP7.85▲ 1 (0.15%)CNERGY4.66▲ 0.21 (0.05%)DCL8.32▲ 0.41 (0.05%)DFML38.94▲ 1.6 (0.04%)DGKC81.94▲ 4.17 (0.05%)FCCL33.42▲ 2.84 (0.09%)FFBL75.71▲ 6.85 (0.10%)FFL12.82▲ 0.96 (0.08%)HUBC110.36▲ 5.86 (0.06%)HUMNL14.01▲ 0.52 (0.04%)KEL5.15▲ 0.5 (0.11%)KOSM7.67▲ 0.5 (0.07%)MLCF39.8▲ 3.36 (0.09%)NBP72.32▲ 6.4 (0.10%)OGDC188.29▲ 8.76 (0.05%)PAEL25.63▲ 1.2 (0.05%)PIBTL7.37▲ 0.22 (0.03%)PPL152.67▲ 8.97 (0.06%)PRL25.39▲ 1.07 (0.04%)PTC17.7▲ 1.3 (0.08%)SEARL82.42▲ 3.85 (0.05%)TELE7.59▲ 0.37 (0.05%)TOMCL32.57▲ 0.6 (0.02%)TPLP8.42▲ 0.29 (0.04%)TREET16.78▲ 0.65 (0.04%)TRG56.04▲ 1.38 (0.03%)UNITY28.78▲ 1.28 (0.05%)WTL1.35▲ 0.06 (0.05%)

Virus vaccine research not for sale

Share
Tweet
WhatsApp
Share on Linkedin
[tta_listen_btn]

Berlin

Germany’s foreign minister said on Monday the rights to coronavirus vaccine research were not for sale, following reports Donald Trump wanted the US to buy exclusive access to a potential vaccine developed by a German biotech firm. The comments, made in an interview to media group Funke, come as scientists raced to develop a vaccine against the deadly coronavirus that has killed some 6,000 people, seen millions placed under lockdown and devastated global markets. “German researchers play a leading role in drug and vaccine development and we cannot allow others to seek exclusive results,” Heiko Maas told Funke. Citing sources close to the German government. –AFP

Related Posts

Get Alerts